Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,367 | Dovepress* | 9,785+ | 1,811 | 11,596 | |
PubMed Central* | 2,582 | 447 | 3,029 | ||
Totals | 12,367 | 2,258 | 14,625 | ||
*Since 5 February 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar